Kinome reprogramming is a targetable vulnerability in ESR1 fusion-driven breast cancer. Gou X, Kim BJ, Anurag M, Lei JT, et al. Cancer Res 2023 Apr 18:CAN-22-3484. doi: 10.1158/0008-5472.CAN-22-3484.

Read + Share

Amedeo Smart

Independent Medical Education

Gou X, Kim BJ, Anurag M, Lei JT, et al. Kinome reprogramming is a targetable vulnerability in ESR1 fusion-driven breast cancer. Cancer Res 2023 Apr 18:CAN-22-3484. doi: 10.1158/0008-5472.CAN-22-3484.
PMID: 37071495